• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity.

作者信息

Huxford Brook, Haque Tahrina, Joseph Aaron Ben, Simonet Cristina, Gallagher David, Budu Caroline, Dobson Ruth, Noyce AlastairJ

机构信息

Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.

Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.

出版信息

Mov Disord. 2022 Feb;37(2):427-428. doi: 10.1002/mds.28829. Epub 2021 Oct 13.

DOI:10.1002/mds.28829
PMID:34643295
Abstract
摘要

相似文献

1
Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity.帕金森病与2型糖尿病：糖化血红蛋白与运动及认知严重程度相关。
Mov Disord. 2022 Feb;37(2):427-428. doi: 10.1002/mds.28829. Epub 2021 Oct 13.
2
Euglycemia Indicates Favorable Motor Outcome in Parkinson's Disease.血糖正常表明帕金森病的运动预后良好。
Mov Disord. 2021 Jun;36(6):1430-1434. doi: 10.1002/mds.28545. Epub 2021 Feb 26.
3
Impact of Glycated Hemoglobin (HbA1c) on cognitive functions in Type 2 diabetic patients.糖化血红蛋白 (HbA1c) 对 2 型糖尿病患者认知功能的影响。
Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5978-5985. doi: 10.26355/eurrev_202110_26875.
4
Glycated haemoglobin (HbA ), diabetes and neuropsychological performance in community-dwelling older adults.社区居住的老年人糖化血红蛋白（HbA）、糖尿病与神经心理表现
Diabet Med. 2021 Nov;38(11):e14668. doi: 10.1111/dme.14668. Epub 2021 Aug 14.
5
Higher serum triglyceride levels are associated with Parkinson's disease mild cognitive impairment.较高的血清甘油三酯水平与帕金森病轻度认知障碍有关。
Mov Disord. 2018 Dec;33(12):1970-1971. doi: 10.1002/mds.27521. Epub 2018 Oct 21.
6
Decreased serum undercarboxylated osteocalcin is associated with cognitive impairment in male patients with type 2 diabetes.血清低羧化骨钙素水平与 2 型糖尿病男性患者认知障碍相关。
J Diabetes Complications. 2018 Jan;32(1):56-60. doi: 10.1016/j.jdiacomp.2017.09.004. Epub 2017 Sep 13.
7
The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.肥胖和血糖控制不佳对认知功能的负面影响：一种可能机制的模型设想
Curr Diab Rep. 2014 Jun;14(6):495. doi: 10.1007/s11892-014-0495-z.
8
Diabetes, Glycated Hemoglobin (HbA1c), and Neuroaxonal Damage in Parkinson's Disease (MARK-PD Study).糖尿病、糖化血红蛋白 (HbA1c) 与帕金森病的神经轴索损伤（MARK-PD 研究）。
Mov Disord. 2022 Jun;37(6):1299-1304. doi: 10.1002/mds.29009. Epub 2022 Apr 6.
9
Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD).血清神经丝与晚期帕金森病（MARK-PD）的运动功能、认知能力下降和亚临床心脏损伤有关。
Parkinsonism Relat Disord. 2021 Sep;90:44-48. doi: 10.1016/j.parkreldis.2021.07.028. Epub 2021 Jul 29.
10
Glycemic Control is Related to Cognitive Dysfunction in Elderly People with Type 2 Diabetes Mellitus in a Rural Chinese Population.血糖控制与中国农村 2 型糖尿病老年患者认知功能障碍的关系。
Curr Alzheimer Res. 2019;16(10):950-962. doi: 10.2174/1567205016666191023110712.

引用本文的文献

1
The Role of HbA1c in Parkinson's Disease: An Integrative Analysis by Single-Cell, Bulk Transcriptome and Mendelian Randomization.糖化血红蛋白A1c在帕金森病中的作用：单细胞、全转录组及孟德尔随机化综合分析
Mol Neurobiol. 2025 May 21. doi: 10.1007/s12035-025-05063-5.
2
Glucose Metabolism Disorders and Parkinson's Disease: Coincidence or Indicator of Dysautonomia?葡萄糖代谢紊乱与帕金森病：巧合还是自主神经功能障碍的指标？
Healthcare (Basel). 2024 Dec 6;12(23):2462. doi: 10.3390/healthcare12232462.
3
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.
2型糖尿病对帕金森病病因的影响。
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.
4
Use of dipeptidyl peptidase-4 inhibitors was associated with a lower risk of Parkinson's disease in diabetic patients.二肽基肽酶-4 抑制剂的使用与糖尿病患者帕金森病发病风险降低相关。
Sci Rep. 2023 Dec 15;13(1):22489. doi: 10.1038/s41598-023-49870-z.
5
Glycated hemoglobin A1c, cerebral small vessel disease burden, and disease severity in Parkinson's disease.糖化血红蛋白 A1c、脑小血管病负担与帕金森病的疾病严重程度。
Ann Clin Transl Neurol. 2023 Dec;10(12):2276-2284. doi: 10.1002/acn3.51913. Epub 2023 Sep 26.
6
How should we be using biomarkers in trials of disease modification in Parkinson's disease?我们应该如何在帕金森病疾病修饰治疗的临床试验中使用生物标志物？
Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265.
7
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical tests.乔杜里帕金森综合征生命体征仪表盘：现实生活中的临床试验凸显的未满足需求。
Front Neurol. 2023 May 25;14:1174698. doi: 10.3389/fneur.2023.1174698. eCollection 2023.
8
Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility.帕金森病与糖尿病：对病理生理学和胃肠动力的协同作用
Curr Gastroenterol Rep. 2023 May;25(5):106-113. doi: 10.1007/s11894-023-00868-7. Epub 2023 Apr 17.